This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2013 Sep 20;31(27):3442-3.

doi: 10.1200/JCO.2013.50.8184. Epub 2013 Aug 19.

Can erlotinib ameliorate cisplatin-induced toxicities?

Jason A Sprowl¹, Ron H Mathijssen, Alex Sparreboom

Affiliations

PMID: 23960178
DOI: 10.1200/JCO.2013.50.8184

Comment

Can erlotinib ameliorate cisplatin-induced toxicities?

Jason A Sprowl et al. J Clin Oncol. 2013.

. 2013 Sep 20;31(27):3442-3.

doi: 10.1200/JCO.2013.50.8184. Epub 2013 Aug 19.

Authors

Jason A Sprowl¹, Ron H Mathijssen, Alex Sparreboom

Affiliation

¹ St Jude Children's Research Hospital, Memphis, TN.

PMID: 23960178
DOI: 10.1200/JCO.2013.50.8184

No abstract available

PubMed Disclaimer

Comment on

Cisplatin and radiotherapy with or without erlotinib in locally advanced squamous cell carcinoma of the head and neck: a randomized phase II trial.
Martins RG, Parvathaneni U, Bauman JE, Sharma AK, Raez LE, Papagikos MA, Yunus F, Kurland BF, Eaton KD, Liao JJ, Mendez E, Futran N, Wang DX, Chai X, Wallace SG, Austin M, Schmidt R, Hayes DN. Martins RG, et al. J Clin Oncol. 2013 Apr 10;31(11):1415-21. doi: 10.1200/JCO.2012.46.3299. Epub 2013 Mar 4. J Clin Oncol. 2013. PMID: 23460709 Clinical Trial.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information